Benjamin Weiss
#140,217
Most Influential Person Now
Benjamin Weiss's AcademicInfluence.com Rankings
Benjamin Weissbiology Degrees
Biology
#9893
World Rank
#13155
Historical Rank
Molecular Biology
#1390
World Rank
#1417
Historical Rank
Neuroscience
#1481
World Rank
#1532
Historical Rank
Biochemistry
#1532
World Rank
#1661
Historical Rank
Download Badge
Chemistry Biology
Benjamin Weiss's Degrees
- PhD Biochemistry University of California, Berkeley
- Bachelors Chemistry Stanford University
Why Is Benjamin Weiss Influential?
(Suggest an Edit or Addition)Benjamin Weiss's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A simple, sensitive method for the assay of adenyl cyclase. (1968) (870)
- Binding of trifluoperazine to the calcium-dependent activator of cyclic nucleotide phosphodiesterase. (1977) (481)
- Mechanism by which psychotropic drugs inhibit adenosine cyclic 3',5'-monophosphate phosphodiesterase of brain. (1976) (360)
- Selective binding of antipsychotics and other psychoactive agents to the calcium-dependent activator of cyclic nucleotide phosphodiesterase. (1979) (350)
- PHARMACOLOGICAL REGULATION OF CALMODULIN * (1980) (322)
- Interaction of drugs with calmodulin. Biochemical, pharmacological and clinical implications. (1982) (302)
- Inhibition of calmodulin by phenothiazines and related drugs: structure-activity relationships. (1982) (254)
- beta-Adrenergic receptors in aged rat brain: reduced number and capacity of pineal gland to develop supersensitivity. (1978) (232)
- Mechanism for selectively inhibiting the activation of cyclic nucleotide phosphodiesterase and adenylate cyclase by antipsychotic agents. (1978) (189)
- Specificity of the binding of trifluoperazine to the calcium-dependent activator of phosphodiesterase and to a series of other calcium-binding proteins. (1978) (182)
- Dipeptidyl Peptidase‐4 Inhibitors Administered in Combination With Metformin Result in an Additive Increase in the Plasma Concentration of Active GLP‐1 (2010) (162)
- Regional and subcellular distribution of adenyl cyclase and 3',5'-cyclic nucleotide phosphodiesterase in brain and pineal gland. (1968) (155)
- Separation of multiple molecular forms of cyclic adenosine-3',5'-monophosphate phosphodiesterase in rat cerebellum by polyacrylamide gel electrophoresis. (1972) (148)
- SELECTIVE STIMULATION OF ADENYL CYCLASE OF RAT PINEAL GLAND BY PHARMACOLOGICALLY ACTIVE CATECHOLAMINES (1968) (148)
- Interrelationships of catecholamines with other endocrine systems. (1966) (132)
- Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum (1993) (127)
- Selective cyclic nucleotide phosphodiesterase inhibitors as potential therapeutic agents. (1977) (126)
- Antisense RNA gene therapy for studying and modulating biological processes (1999) (114)
- Enzymatic regulation of the concentration of cyclic GMP in mouse brain (1978) (112)
- Selective Alteration of the Activity of the Multiple Forms of Adenosine 3', 5'-Monophosphate Phosphodiesterase of Rat Cerebrum (1974) (108)
- Effect of norepinephrine on the concentration of adenosine 3',5'-monophosphate of rat pineal gland in organ culture. (1972) (100)
- In vivo administration of an oligodeoxynucleotide antisense to the D2 dopamine receptor messenger RNA inhibits D2 dopamine receptor-mediated behavior and the expression of D2 dopamine receptors in mouse striatum. (1994) (96)
- Rapid microassay of adenosine 3',5'-monophosphate phosphodiesterase activity. (1972) (96)
- Ability of aged rats to alter beta adrenergic receptors of brain in response to repeated administration of reserpine and desmethylimipramine. (1979) (92)
- Effects of phenothiazine tranquilizers on the cyclic 3',5'-adenosine monophosphate system of rat brain. (1971) (88)
- Antisense oligodeoxynucleotide inhibits D2 dopamine receptor-mediated behavior and D2 messenger RNA (1993) (85)
- ONTOGENETIC DEVELOPMENT OF ADENYL CYCLASE AND PHOSPHODIESTERASE IN RAT BRAIN (1971) (81)
- Evidence for a role of adenosine 3',5'-monophosphate in adipose tissue lipolysis. (1966) (79)
- Chapter 16 – Mechanisms and Pharmacological Implications of Altering Calmodulin Activity (1980) (77)
- Chronic guanethidine treatment increases cardiac β-adrenergic receptors (1978) (74)
- Effects of environmental lighting and chronic denervation on the activation of adenyl cyclase of rat pineal gland by norepinephrine and sodium fluoride. (1969) (73)
- Adenosine 3',5'-monophosphate concentrations and isoproterenol-induced synthesis of deoxyribonucleic acid in mouse parotid gland. (1972) (73)
- MICROASSAY OF ADENOSINE‐3′,5′‐MONOPHOSPHATE (CYCLIC AMP) IN BRAIN AND OTHER TISSUES BY THE LUCIFERIN‐LUCIFERASE SYSTEM 1 (1971) (70)
- Inhibition of calmodulin activity by insect venom peptides. (1983) (69)
- Age-related alterations in the development of adrenergic denervation supersensitivity. (1979) (66)
- Gonadal hormones as regulators of pineal adenyl cyclase activity. (1970) (65)
- Antisense strategies in neurobiology (1997) (63)
- Dopaminergic and glutamatergic blocking drugs differentially regulate glutamic acid decarboxylase mRNA in mouse brain. (1994) (63)
- Regional Distribution of Calmodulin Activity in Rat Brain (1985) (58)
- Neuronal localization and modulation of the D2 dopamine receptor mRNA in brain of normal mice and mice lesioned with 6-hydroxydopamine (1991) (58)
- Lesions of Mouse Striatum Induced by 6‐Hydroxydopamine Differentially Alter the Density, Rate of Synthesis, and Level of Gene Expression of D1 and D2 Dopamine Receptors (1994) (58)
- The increase of calmodulin in PC12 cells induced by NGF is caused by differential expression of multiple mRNAs for calmodulin (1991) (57)
- Inhibition by trifluoperazine of calmodulin-induced activation of ATPase activity of rat erythrocyte (1980) (57)
- Ontogenetic expression of D2 dopamine receptor mRNA in rat corpus striatum. (1991) (56)
- Multiple forms of cyclic 3',5'-AMP phosphodiesterase of rat cerebrum and cloned astrocytoma and neuroblastoma cells. (1974) (54)
- Oligodeoxynucleotide antisense to the D1 dopamine receptor mRNA inhibits D1 dopamine receptor-mediated behaviors in normal mice and in mice lesioned with 6-hydroxydopamine. (1994) (51)
- Effect of continuous exposure to selective D1 and D2 dopaminergic agonists on rotational behavior in supersensitive mice. (1989) (47)
- Photoaffinity labeling of calmodulin byphenothiazine antipsychotics. (1981) (47)
- ONTOGENETIC DEVELOPMENT OF A PHOSPHODIESTERASE ACTIVATOR AND THE MULTIPLE FORMS OF CYCLIC AMP PHOSPHODIESTERASE OF RAT BRAIN (1974) (45)
- Sympathetic nervous control of adipose tissue lipolysis. (1968) (43)
- Subsensitivity of the beta-adrenergic receptor-linked adenylate cyclase system of rat pineal gland following repeated treatment with desmethylimipramine and nialamide. (1981) (43)
- Opposite effects of acute and repeated administration of desmethylimipramine on adrenergic responsiveness in rat pineal gland. (1979) (41)
- Increased response to catecholamines of the cyclic AMP system of rat pineal gland induced by decreased sympathetic activity. (1974) (40)
- Impaired recovery of alpha 1- and alpha 2-adrenergic receptors in brain tissue of aged rats. (1984) (40)
- Developmental and age-related changes in the D2 dopamine receptor mRNA subtypes in rat brain (1992) (38)
- Interaction of beta-endorphin and other opioid peptides with calmodulin. (1982) (38)
- Neuroendocrine control of the cyclic AMP system of brain and pineal gland. (1972) (38)
- Reversal of supersensitive apomorphine-induced rotational behavior in mice by continuous exposure to apomorphine. (1986) (37)
- Antisense strategies in dopamine receptor pharmacology. (1997) (36)
- Increased cyclic nucleotide phosphodiesterase activity in leukaemic lymphocytes (1976) (34)
- D2 dopamine receptor antisense oligodeoxynucleotide inhibits the synthesis of a functional pool of D2 dopamine receptors. (1995) (34)
- Techniques for measuring the interaction of drugs with calmodulin. (1983) (33)
- Similarities and differences in the norepinephrine-and sodium fluoride-sensitive adenyl cyclase system. (1969) (30)
- Anatomical localization of calmodulin mRNA in the rat brain with cloned cDNA and synthetic oligonucleotide probes (1990) (29)
- Ontogenetic development of calmodulin mRNA in rat brain using in situ hybridization histochemistry. (1990) (29)
- Differential activation and inhibition of the multiple forms of cyclic nucleotide phosphodiesterase. (1975) (28)
- Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole. (1991) (28)
- Effect of long-term changes in sympathetic nervous activity on the beta-adrenergic receptor-adenylate cyclase complex of rat pineal gland. (1981) (28)
- Psychopharmacological agents and the cyclic AMP system of rat brain. (1972) (27)
- Properties and drug responsiveness of cyclic nucleotide phosphodiesterases of rat lung. (1976) (27)
- Characteristics of the cyclic nucleotide phosphodiesterases of normal and leukemic lymphocytes. (1977) (27)
- Irreversible blockade of D2 dopamine receptors by fluphenazine-N-mustard increases D2 dopamine receptor mRNA and proenkephalin mRNA and decreases D1 dopamine receptor mRNA and mu and delta opioid receptors in rat striatum (1994) (26)
- Interaction of alpha adrenergic antagonists with calmodulin. (1984) (25)
- Differential ontogenetic expression and regulation of proenkephalin and preprosomatostatin mRNAs in rat caudate-putamen as studied by in situ hybridization histochemistry. (1991) (25)
- D2 dopamine receptor messenger RNA is altered to a greater extent by blockade of glutamate receptors than by blockade of dopamine receptors (1994) (25)
- Electrical stimulation of sympathetic nerves increases the concentration of cyclic AMP in rat pineal gland. (1981) (24)
- Distribution of cyclic adenosine monophosphate in rat brain. (1971) (23)
- Discussion of the formation, metabolism, and physiologic effects of melatonin. (1968) (22)
- Effect of glycine derivatives on beharioral changes induced by 3-mercaptopropionic acid or phencyclidine in mice (1986) (21)
- Antisense oligodeoxynucleotides and antisense RNA : novel pharmacological and therapeutic agents (1997) (21)
- A microassay for guanosine 3',5'-monophosphate phosphodiesterase activity. (1974) (20)
- Acute and chronic effects of psychoactive drugs on adrenergic receptors and calmodulin. (1980) (19)
- Cholinergic lesions of mouse striatum induced by AF64A alter D2 dopaminergic behavior and reduce D2 dopamine receptors and D2 dopamine receptor mRNA (1993) (18)
- Pharmacological control of the synthesis and metabolism of cyclic nucleotides. (1977) (18)
- Irreversible blockade of D2 dopamine receptors by fluphenazine-N-mustard increases glutamic acid decarboxylase mRNA in rat striatum (1993) (18)
- CHAPTER 4 – Calmodulin Antagonists: Structure—Activity Relationships (1985) (17)
- Adenylate cyclase and phosphodiesterase activity of normal and SV40 virus-transformed hamster astrocytes in cell culture (1971) (17)
- Neurobiological significance of cyclic 3',5'-adenosine monophosphate. (1969) (17)
- Modulation of Adrenergic Receptors During Aging (1988) (16)
- Comparison of the effects of fluphenazine-n-mustard on dopamine binding sites and on behavior induced by apomorphine in supersensitive mice (1987) (15)
- Modulation of Catecholaminergic Receptors During Development and Aging (1984) (15)
- Selective down-regulation of D1 dopamine mediated rotational behavior in supersensitive mice (1988) (14)
- D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors. (1998) (14)
- Effect of sympathetic input on ontogeny of β-adrenergic receptors in rat pineal gland (1981) (13)
- Biochemical and possible neuropsychopharmacological implications of inhibiting calmodulin activity. (1983) (12)
- Interaction of various peptides with calmodulin. (1984) (11)
- Dopamine receptor blockade increases dopamine D2 receptor and glutamic acid decarboxylase mRNAs in mouse substantia nigra. (1994) (11)
- INTRASTRIATAL ADMINISTRATION OF AN OLIGODEOXYNUCLEOTIDE ANTISENSE TO THE D2 DOPAMINE RECEPTOR mRNA INHIBITS D2 DOPAMINE RECEPTOR-MEDIATED BEHAVIOR AND D2 DOPAMINE RECEPTORS IN NORMAL MICE AND IN MICE LESIONED WITH 6-HYDROXYDOPAMINE (1996) (11)
- Inhibition of growth of l1210 leukemic cells by inhibitors of cyclic nucleotide phosphodiesterase (pde) and calmodulin (cal). Abstr. (1983) (11)
- Differential regulation of release of acetylcholine in the striatum in mice following continuous exposure to selective D1 and D2 dopaminergic agonists (1993) (11)
- Neural and hormonal regulation of pineal adenyl cyclase activity. (1970) (10)
- Mechanisms of Pharmacologically Altering Calmodulin Activity (1985) (10)
- Differential inhibition of calcium-dependent and calmodulin-dependent enzymes by drug-calmodulin adducts. (1990) (10)
- D2 dopamine receptor antisense increases the activity and mRNA of tyrosine hydroxylase and aromatic l-amino acid decarboxylase in mouse brain (1996) (10)
- Expression of a D2 dopamine receptor antisense RNA in brain inhibits D2-mediated behaviors (1997) (10)
- Cyclic nucleotide phosphodiesterase of normal and leukemic lymphocytes. Kinetic properties and selective alteration of the activity of the multiple molecular forms. (1979) (9)
- Immunocytochemical localization of calmodulin in PC12 cells and its possible interaction with histones (1995) (8)
- Characteristics of the binding of phenoxybenzamine to calmodulin. (1988) (8)
- Continuous infusion of clozapine increases Mu and delta opioid receptors and proenkephalin mRNA in mouse brain (1995) (8)
- Selective protection from the inhibition by EEDQ of D1 and D2 dopamine agonist-induced rotational behavior in mice (1988) (8)
- Characteristics of the cyclic nucleotide phosphodiesterases in a transplantable pheochromocytoma and adrenal medulla of the rat. (1978) (8)
- Modulation of the beta-adrenergic receptor-adenylate cyclase system following acute and repeated treatment with antidepressants. (1982) (8)
- Analyses of cyclic nucleotide phosphodiesterases in lymphocytes from normal and aged leukemic mice. (1978) (7)
- Denervation supersensitivity and beta-adrenergic receptors as a function of age. (1980) (7)
- [10] Measurement of the activity of cyclic nucleotide phosphodiesterases with firefly luciferin-luciferase coupled assay systems (1978) (7)
- Modulation of beta-adrenergic receptors and calmodulin following acute and chronic treatment with neuroleptics. (1980) (6)
- Differential inhibition of calmodulin-sensitive phosphodiesterase and Ca++-adenosine triphosphatase by chlorpromazine-linked calmodulin. (1987) (6)
- Interaction of neuropeptides with calmodulin: a structure-activity study. (1983) (6)
- Uptake and distribution of fluorescein-labeled D2 dopamine receptor antisense oligodeoxynucleotide in mouse brain (2007) (5)
- D 2 Dopamine Antisense RNA Expression Vector , Unlike Haloperidol , Produces Long-term Inhibition of D 2 Dopamine-Mediated Behaviors without Causing Up-regulation of D 2 Dopamine Receptors 1 (1998) (5)
- Entrapment of phenylalanine hydroxylase in a polyacrylamide matrix. (1977) (5)
- AF64A lesions of mouse striatum result in ipsilateral rotations to D2 dopamine agonists but contralateral rotations to muscarinic cholinergic agonists. (1993) (5)
- Continuously infusing quinpirole decreases Ca2+/Calmodulin-dependent phosphorylation in mouse striatum (1993) (4)
- Effect of mineralocorticoids on the paradoxical glucose-induced hyperkalemia in nondiabetic patients with selective hypoaldosteronism. (1977) (4)
- SELECTIVE REGULATION OF THE MULTIPLE FORMS OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE BY NOREPINEPHRINE AND OTHER AGENTS (1973) (4)
- Pharmacological Inhibition of Dopaminergic and Other Neurotransmitter Receptors Using Antisense Oligodeoxynucleotides (1998) (4)
- Triazolam blocks the initial rotational effects of quinpirole but permits the later developing reduction of dopamine D2-mediated rotational behavior and dopamine D2 receptors. (1992) (3)
- Effects of Dopamine Receptor Antisense RNA Expression Vectors in The Nervous System (1998) (3)
- Differential effects of fluphenazine-N-mustard, on calmodulin activity and on D1 and D2 dopaminergic responses (2004) (2)
- Effect of bestatin analogues and other compounds on enkephalin hydrolysis by an aminopeptidase from the mesophiles pseudomonas sp ATCC 11299A and chromobacterium violaceum ATCC 12540. (1983) (2)
- Cyclic AMP phosphodiesterase activity of murine T and B lymphocytes. (1978) (2)
- MODULATION OF CYCLIC NUCLEOTIDE METABOLISM BY ANTIPSYCHOTICS THROUGH A NON-DOPAMINE RECEPTOR (1979) (2)
- Age-related changes in the binding of 3H-dihydroalprenolol in rat brain [proceedings]. (1978) (2)
- In situ hybridization histochemistry as a tool to study gene expression and its regulation in the central nervous system. (1989) (2)
- Covalent coupling of rat liver phenylalanine hydroxylase (1978) (2)
- D2 dopamine receptor antisense increases the activity and mRNA of tyrosine hydroxylase and aromatic L-amino acid decarboxylase in mouse brain. (1996) (1)
- Regulation of the multiple molecular forms of cyclic nucleotide phosphodiesterase (1973) (1)
- Cyclic nucleotides in disease : [proceedings of the symposium, Cyclic nucleotides in disease (1975) (1)
- Aminothiols: synthesis and effect on chicken brain aminopeptidases. (1988) (1)
- PROTEIN METABOLISM AND AMINO ACID ACCUMULATION IN THE RAT SUBMAXILLARY GLAND DURING REDUCED SYMPATHETIC ACTIVITY (1971) (1)
- V. Efforts at stabilization of rat liver phenylalanine hydroxylase. (1979) (1)
- Regional distribution of cyclic 3',5'-AMP in rat brain. (1970) (1)
- Effect of various compounds on enkephalin hydrolysis by an aminopeptidase from the thermophiles Thermomonospora fusca ATCC 27730 and Thermus thermophilus ATCC 27634. (1983) (1)
- Quantitative and qualitative differences in cyclic amp phos- phodiesterase of murine t and b lymphocytes. Abstr. (1978) (0)
- Effect of several amino acid phosphonates and related compounds on rat brain aminopeptidases. (1987) (0)
- Antisense strategies for modulating dopaminergic behavior (1994) (0)
- Pharmacological and Molecular Regulation of the Expression of Dopamine Receptors (2017) (0)
- Attempts at induction of phenylalanine hydroxylase in thermophilic bacteria and induction of thermophily in mesophiles. (1981) (0)
- III. Covalent coupling of rat liver phenylalanine hydroxylase. (1977) (0)
- Clozapine produces different effects from those of fluphenazine-N-mustard on receptors and mRNAs associated with dopaminergic and opioid peptidergic systems of mouse brain (1993) (0)
- Effect of several amino acid phosphonates and other compounds on rat brain and kidney peptidases. (1986) (0)
- Effect of treatment with desmethylimipramine (DMI) on the rise of cyclic AMP in rat pineal gland following stimulation of its sympathetic input (1980) (0)
- IV. Covalent coupling of rat liver phenylalanine hydroxylase. (1978) (0)
- 2668 – RESERPINE-INDUCED INCREASE IN THE DENSITY OF β-ADRENERGIC RECEPTORS IN AGING RAT BRAIN (1978) (0)
- Effects of amino acid amides and aminothiols on 3-mercaptoproprionic acid-induced convulsions and phenylcyclidine-induced hyperactivity in mice (1990) (0)
- Effects of N-terminal derivatives of aminoacids on rat brain peptidases and on induced convulsions in mice (1990) (0)
- VI. Efforts at stabilization of rat liver phenylalanine hydroxylase. (1979) (0)
- Characteristics of cyclic nucleotide phosphodiesterase of normal and leukemic lymphocytes. Abstr. (1976) (0)
- DIFFERENTIALSYNTHESISOF RIBONUCLEICACID IN PROSTATICNUCLEI:EVIDENCEFOR SELECTIVEGENE TRANSCRIPTIONINDUCED BY ANDROGENS* (1966) (0)
- Effects of various amides on a rat brain puromycin-sensitive aminopeptidase and on induced convulsions in mice (1992) (0)
This paper list is powered by the following services:
